OMICS International

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer

 

Recommended Conferences for Medicine for Flu

Medicine for Flu


As per available reports about 8 through its relevant journals, 7 Conferences, 181 workshops, are presently dedicated exclusively to Medicine for Flu and about 1599 articles are being published on Medicine for Flu.

Most people with the flu have mild illness and do not need medical care or antiviral drugs. If you get sick with flu symptoms, in most cases, you should stay home and avoid contact with other people except to get medical care. Certain people are at high risk of serious flu-related complications and this is true both for seasonal flu and novel flu virus infections. If you are in a high risk group and develop flu symptoms, it’s best for you to contact your doctor. Remind them about your high risk status for flu.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Scope and Importance:

The term influenza refers to illness caused by influenza virus. This is commonly called the flu, but many different illnesses cause flu-like symptoms such as fever, chills, aches and pains, cough, and sore throat. Influenza can cause different illness patterns, ranging from mild common cold symptoms, to typical flu, to life-threatening pneumonia, bacterial infections and other complications. There are a number of drugs approved by FDA for the treatment and prevention of influenza. Vaccination is the primary means of preventing and controlling influenza. Antibiotics are used to treat illnesses caused by bacteria. Examples of illnesses caused by bacteria include strep throat, tuberculosis and many types of pneumonia. Antibiotics do not treat viral illnesses like flu, colds, and most sore throats.

Treatments for influenza include a range of medications and therapies that are used in response to disease influenza. Treatments may either directly target the influenza virus itself; or instead they may just offer relief to symptoms of the disease, while the body's own immune system works to recover from infection. The two main classes of antiviral drugs used against influenza are neuraminidase inhibitors, such as zanamivir and oseltamivir, or inhibitors of the viral M2 protein, such as amantadine and rimantadine. These drugs can reduce the severity of symptoms if taken soon after infection and can also be taken to decrease the risk of infection.
However, virus strains have emerged that show drug resistance to both classes of drug. Antiviral drugs directly target the viruses responsible for influenza infections. Generally, anti-viral drugs work optimally when taken within a few days of the onset of symptoms.[citation needed] Certain drugs are used prophylactically, that is they are used in uninfected individuals to guard against infection. Four licensed influenza antiviral agents are available in the United States: amantadine, rimantadine, zanamivir, and oseltamivir. They are available through prescription only. These drugs fall into categories as either M2-inhibitors (admantane derivatives) or neuraminidase inhibitors as illustrated in the following table. Influenza viruses can show resistance to anti-viral drugs. Like the development of bacterial antibiotic resistance, this can result from over-use of these drugs. For example, a recent study published in the June 2009 Issue of Nature Biotechnology emphasized the urgent need for augmentation of oseltamivir (Tamiflu) stockpiles with additional antiviral drugs including zanamivir (Relenza) based on an evaluation of the performance of these drugs in the scenario that the 2009 H1N1 'Swine Flu' neuraminidase (NA) were to acquire the Tamiflu-resistance mutation which is currently widespread in seasonal H1N1 strains. Yet another example is in the case of the amantadines treatment may lead to the rapid production of resistant viruses, and over-use of these drugs has probably contributed to the spread of resistance. In particular, this high-level of resistance may be due to the easy availability of amantadines as part of over-the-counter cold remedies in countries such as China and Russia, and their use to prevent outbreaks of influenza in farmed poultry
 

Market Analysis:

The market of Flu consists of products to prevent, treat, and diagnose influenza viruses during both seasonal and pandemic episodes. Also included in the market is the stockpiling efforts and spending on new vaccine/therapeutic contracts. The global influenza market will grow from nearly $3.8 billion in 2012 to $4 billion in 2013. Global influenza market to be worth $6.3 billion in 2014 for a compound annual growth rate (CAGR) of 2.7%.This year, the global market for products used in the fight against influenza will be worth an estimated $5.5 billion, according to a new technical market research report, the Global Influenza Market, from BCC Research.

International symposium and workshops:

  • Influenza activity - United States
  • EFIS-EJI South Eastern European Immunology School (SEEIS2015)16 - 19 October 2015 in Becici, Montenegro
  • ESWI Influenza Conferences, 11-14 September 2011 in Malta
  • Multinational Influenza Seasonal Mortality Study (MISMS) Workshop October 13-15th, 2015, National Taiwan University, Taipei, Taiwan
  • 3rd ASM Conference on Viral Manipulation of Nuclear Processes
  • 22nd International Symposium on Hepatitis C Virus and Related Viruses - October 9-13, 2015
  • 5th International Workshop on HIV & Aging took place on 20 - 21 October 2014 at the Royal Sonesta Harbor Court Hotel in Baltimore, MD, USA
  • 10th International Workshop on HIV Transmission - Principles of Intervention, to be held in Atlanta, GA, USA on December 5-6, 2015
  • 9th International Workshop on HIV Transmission - Principles of Intervention, was held in Cape Town, South Africa
  • Conference on Retroviruses and Opportunistic Infections (CROI)

List of Best International Conferences :

Relevant Society and Associations:

  • San Francisco Medical Society
  • Microbiology & Quality Associates, Inc
  • American Lung Association in California
  • Northern California Clinical Research Center
  • International Society for Influenza and other Respiratory Virus Disease
  • American Society for Microbiology
  • American society of virology
  • International Society for Antiviral research
  • American Lung Association
  • Infectious Diseases Society of America
  • European society of virology
  • Vivaldi Biosciences Inc
  • Society for In Vitro Biology
  • Pan American Society for Clinical Virology
  • European Society for Clinical Virology
  • Bill & Melinda Gates Foundation
  • FLURESP
  • Influenza Specialist Group
  • International Society for Infectious Diseases
  • Hellenic Society of Virology


Companies :

  • Chiron Corporation
  • Vaxart
  • Novartis
  • Inovio Pharmaceuticals
  • Novarx
  • Flugen
  • Sanofi Pasteur
  • Celldex Therapeutics
  • Emergent BioSolutions
  • Immunomic Therapeutics
  • GlaxoSmithKline
  • Gamma Vaccines
  • bioCSL (CSL)
  • Bavarian Nordic
  • Bharat Biotech
  • Indian Immunologicals
  • Pfizer
  • MedImmune (AstraZeneca)
  • NovaDigm Therapeutics
  • Crucell (Janssen Pharmaceutical)
  • Merck
  • Lonza
  • Pharmajet
List of Journals
  • Journal of AIDS and Clinical Research
  • Journal of Clinical and Cellular Immunology
  • Journal of Antivirals and Antiretrovirals
  • Journal of Infectious Diseases and Therapy
  • Virology and Mycology
  • Journal of Vaccines and Vaccination

This page will be updated regularly.

This page was last updated on 14th Sep, 2015

Conferenceseries Destinations

Contact Us

Medical Conferences
Jessie Grace
jessie.grace@conferenceseries.com
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
badoni.victor@conferenceseries.com
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
walker.smith@conferenceseries.com
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
jennifer.leny@conferenceseries.com
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
stanley.knight@conferenceseries.com
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
sandeep@conferenceseries.com
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
rohit.casper@conferenceseries.com
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
ravi.vittal@conferenceseries.com
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
lucygrey@conferenceseries.com
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
stephen.bruce@conferenceseries.com
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
dolly@conferenceseries.com
+1-702-508-5200 Ext:8051

Program Enquiries
Symposia/Workshops
Sponsorships
Media Partners | Advertising